What is the current Medical Artificial Heart Valve market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Medical Artificial Heart Valve market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Medical Artificial Heart Valve market?

Increasing demand for minimally invasive procedures drives the market.

What challenges does the Medical Artificial Heart Valve market face?

High costs and limited reimbursement options pose significant challenges.

Which regions are leaders in the Medical Artificial Heart Valve market?

North America and Europe are the leading regions in the market.

Who are the top companies in the Medical Artificial Heart Valve market?

Top companies include Edwards Lifesciences and Medtronic.

What future opportunities exist in the Medical Artificial Heart Valve market?

Emerging markets and technological advancements offer future opportunities.

How does technology impact the Medical Artificial Heart Valve market?

Advances in material science and 3D printing impact the market.

What is the current regulatory landscape for the Medical Artificial Heart Valve market?

Stringent regulations and approvals are required for market entry.

What is the future outlook for the Medical Artificial Heart Valve market?

The market is expected to experience significant growth due to increasing demand.

Medical Artificial Heart Valve Market Potential & Strategic Outlook 2033

Medical Artificial Heart Valve by Application (Hospitals, Ambulatory Surgical Centers), by Types (Spherical Cage Flap, Oblique Disc, Double Leaf Flap, Biopetal with Stent, Biopetal without Stent, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 12.1%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Medical Artificial Heart Valve Market Overview

The Medical Artificial Heart Valve market refers to the industry that produces and distributes artificial heart valves used to replace diseased or damaged heart valves. As a critical component of the cardiovascular device market, the Medical Artificial Heart Valve market size is estimated to be around $6.4 billion in 2025. The growth outlook for this market is promising, with a market forecast expected to reach $10.8 billion by 2033, driven by an increasing prevalence of heart valve diseases and advancements in medical technology. The industry expansion is expected to be driven by a compound annual growth rate (CAGR) of 6.5% during the forecast period. Key forces shaping the industry include technology shifts towards minimally invasive procedures, regulations and standards for device approval, and changing consumer behavior towards seeking advanced treatments.

Loading chart…

The largest region in the Medical Artificial Heart Valve market is North America, driven by a high prevalence of heart valve diseases and a well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, driven by an increasing demand for advanced medical devices and a growing healthcare infrastructure. The market is expected to be driven by key forces such as technology shifts towards minimally invasive procedures, regulations and standards for device approval, and changing consumer behavior towards seeking advanced treatments. As the market continues to evolve, it is essential for industry players to stay ahead of the curve and adapt to the changing landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.99 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Edwards Lifesciences; Medtronic; Abbott; Boston Scientific; Venus Medtech; Meril Life Sciences; Braile Biomedica; Symetis SA; Jenavalve Technology; Lepu Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Medical Artificial Heart Valve market is poised for significant growth, driven by factors such as increasing prevalence of heart valve disorders and advancements in medical technology. The Medical Artificial Heart Valve market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in transcatheter technologies have improved the efficacy and safety of artificial heart valve procedures, driving adoption rates and contributing to the growth of the Medical Artificial Heart Valve market.

The rising geriatric population and corresponding increase in heart valve disorders have created a large patient pool, fueling demand for artificial heart valves and supporting the growth forecast of the Medical Artificial Heart Valve market.

Restraints2 items

High costs associated with artificial heart valve procedures and devices may limit access to these life-saving treatments, particularly in low-income countries, thereby restraining the growth of the Medical Artificial Heart Valve market size.

Stringent regulatory frameworks and rigorous testing requirements can delay the approval and commercialization of new artificial heart valve products, hindering the growth of the Medical Artificial Heart Valve market.

Opportunities2 items

Emerging markets in Asia and Latin America offer significant opportunities for expansion, driven by growing healthcare infrastructure and increasing demand for advanced medical devices, including artificial heart valves, which will contribute to the Medical Artificial Heart Valve market size.

The development of next-generation artificial heart valves with improved durability and performance characteristics presents opportunities for market players to differentiate themselves and capture a larger share of the Medical Artificial Heart Valve market.

Challenges2 items

The Medical Artificial Heart Valve market faces challenges related to supply chain disruptions, which can impact the availability of critical components and raw materials, ultimately affecting the growth forecast of the Medical Artificial Heart Valve market size.

Intense competitive pressures and pricing constraints may erode profit margins for market players, making it essential for companies to develop strategies that balance pricing with innovation and customer value in the Medical Artificial Heart Valve market.

Market Segmentation

Loading chart…

The Medical Artificial Heart Valve market can be segmented based on Application, which includes transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). This segmentation contributes to the overall market size by highlighting the different areas where artificial heart valves are used, allowing for a more nuanced understanding of the market's dynamics. The Medical Artificial Heart Valve segmentation is crucial in identifying the key applications that drive the market's growth.

Another way to segment the Medical Artificial Heart Valve market is by Types, which includes subtypes such as mechanical valves and bioprosthetic valves. This segmentation is essential in understanding the different types of artificial heart valves available, each with its own set of advantages and disadvantages. By analyzing the market taxonomy, researchers can identify the most commonly used types of artificial heart valves and their respective market shares, ultimately contributing to the overall market size.

Medical Artificial Heart Valve Segmentation Breakdown10 items

Application

Hospitals

Ambulatory Surgical Centers

Types

Spherical Cage Flap

Oblique Disc

Double Leaf Flap

Biopetal with Stent

Biopetal without Stent

Others

Regional Insights

Loading chart…

The Medical Artificial Heart Valve market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market, driven by high adoption rates of advanced medical technologies, favorable reimbursement policies, and significant investments in healthcare infrastructure. The fastest-growing region is expected to be Asia Pacific, fueled by increasing demand for artificial heart valves, rising healthcare expenditure, and growing ecosystem maturity.

In North America, key drivers include high adoption rates of minimally invasive procedures, favorable policies supporting medical device innovation, and significant investments in research and development. In Europe, drivers comprise growing demographics of the aging population, increasing infrastructure development in healthcare, and rising ecosystem maturity. Asia Pacific's growth is driven by rising healthcare expenditure, growing demand for artificial heart valves, and increasing foreign investments. Latin America's growth is fueled by improving healthcare infrastructure, rising adoption of medical technologies, and growing regional forecast. The Middle East & Africa region is driven by increasing healthcare spending, growing demand for advanced medical treatments, and rising partnerships between local and international healthcare providers.

Competitive Landscape

The Medical Artificial Heart Valve market is moderately consolidated, with a mix of global players and local companies competing for market share. The Medical Artificial Heart Valve competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are leveraging their strong distribution networks and brand reputation to maintain their market position, while local companies are focusing on regional expansion and customization to gain traction.

Companies in the Medical Artificial Heart Valve market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization, which are forcing them to rethink their business models and focus on cost advantages, technology, and service models. The following companies are focusing on specific strategic initiatives:

Edwards Lifesciences: regional expansion

Medtronic: innovation pipeline

Abbott: premium pricing

Boston Scientific: OEM tie-ups

Venus Medtech: local manufacturing

Meril Life Sciences: vertical integration

Key Medical Artificial Heart Valve Companies10 items

Edwards Lifesciences

Medtronic

Abbott

Boston Scientific

Venus Medtech

Meril Life Sciences

Braile Biomedica

Symetis SA

Jenavalve Technology

Lepu Medical Technology

Market Ecosystem

The Medical Artificial Heart Valve ecosystem encompasses a complex network of stakeholders, spanning upstream technology providers and suppliers to downstream end users. This value chain analysis reveals how value is created and captured across the ecosystem, from research and development to manufacturing, distribution, and patient care. The ecosystem can be broadly segmented into three tiers: upstream, midstream, and downstream, with each tier comprising distinct participants that contribute to the creation and delivery of medical artificial heart valves.

Raw material suppliers — provide biomaterials and components

OEMs / manufacturers — design and produce artificial heart valves

Technology providers — develop valve technologies and software

System integrators / EPCs — integrate valves into larger medical systems

Distributors / channel partners — supply valves to healthcare providers

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce safety and efficacy standards

The flow of value through the Medical Artificial Heart Valve ecosystem is influenced by various control points, including regulatory approvals, clinical trials, and reimbursement policies. Dependency risks, such as input constraints and standards compliance, can impact the availability and adoption of artificial heart valves. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between ecosystem participants. The ecosystem's dynamics can also vary by region, with different regulatory frameworks, healthcare systems, and patient needs shaping the value chain analysis in distinct markets.

Recent Industry Insights

The Medical Artificial Heart Valve industry has witnessed significant developments over the last 12-18 months, shaping the future of the market. Recent partnerships, such as the collaboration between leading medical device manufacturers and research institutions, have accelerated innovation in the field. Mergers and acquisitions, like the acquisition of a prominent artificial heart valve manufacturer, have also contributed to the industry's growth.

Furthermore, the launch of advanced product technologies, including 3D-printed heart valves, has transformed the Medical Artificial Heart Valve industry trends. Regulatory changes, such as the approval of new valve replacement procedures, have also expanded the market's potential. These developments have led to a shift in consumer and enterprise trends, with a growing focus on minimally invasive procedures and personalized medicine, ultimately driving the Medical Artificial Heart Valve industry trends forward.

Analyst Overview

As the Lead Analyst for this study, I can confidently state that the Medical Artificial Heart Valve market outlook is promising, driven by an aging population and an increasing prevalence of heart valve diseases. The market attractiveness is high, with a growing demand for minimally invasive procedures and advancements in technology. However, the competitive intensity is moderate, with a few key players dominating the market.

The long-term outlook for the Medical Artificial Heart Valve market is positive, with innovation being a key driver of growth. The demand-supply balance is expected to be stable, with manufacturers investing in research and development to meet the growing demand. However, key risk factors such as regulatory challenges and reimbursement issues may impact the market. Overall, the market is expected to experience significant growth, driven by an increasing focus on patient outcomes and technological advancements.

12 items

1. Executive Summary

2. Medical Artificial Heart Valve Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Medical Artificial Heart Valve Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Medical Artificial Heart Valve Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Medical Artificial Heart Valve Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Medical Artificial Heart Valve Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Medical Artificial Heart Valve Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Medical Artificial Heart Valve Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Medical Artificial Heart Valve Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Medical Artificial Heart Valve Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Medical Artificial Heart Valve Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Medical Artificial Heart Valve Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Medical Artificial Heart Valve Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Medical Artificial Heart Valve Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Medical Artificial Heart Valve Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Medical Artificial Heart Valve Market Competition by Key Manufacturers

9.1. Global Medical Artificial Heart Valve Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Medical Artificial Heart Valve: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Edwards Lifesciences

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Medtronic

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Abbott

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Boston Scientific

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Venus Medtech

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Meril Life Sciences

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Braile Biomedica

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Symetis SA

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Jenavalve Technology

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Lepu Medical Technology

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Medical Artificial Heart Valve Market

Figure 4: Global Medical Artificial Heart Valve Market: Drivers

Figure 5: Global Medical Artificial Heart Valve Market: Challenges

Figure 6: Global Medical Artificial Heart Valve Market: Trends

Figure 7: Global Medical Artificial Heart Valve Market: Opportunity

Figure 8: Global Medical Artificial Heart Valve Market: Restraint

Figure 9: Global Medical Artificial Heart Valve Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Medical Artificial Heart Valve Market Value (USD Million) By Region

Figure 19: Global Medical Artificial Heart Valve Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Medical Artificial Heart Valve Market Value (USD Million) By Region

Figure 27: Global Medical Artificial Heart Valve Market Share (%) By: Regions (2032)

Figure 28: Global Medical Artificial Heart Valve Market Volume (K) By Region

Figure 29: Global Medical Artificial Heart Valve Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Medical Artificial Heart Valve Market Value (USD Million) By Region

Figure 37: Global Medical Artificial Heart Valve Market Share (%) By: Regions (2032)

Figure 38: Global Medical Artificial Heart Valve Market Volume (K) By Region

Figure 39: Global Medical Artificial Heart Valve Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Medical Artificial Heart Valve Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Medical Artificial Heart Valve Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Medical Artificial Heart Valve Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Medical Artificial Heart Valve Market Value (USD Million) By Region

Table 14: Global Medical Artificial Heart Valve Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Medical Artificial Heart Valve Market Volume (K) By Region

Table 31: Global Medical Artificial Heart Valve Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Medical Artificial Heart Valve Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Medical Artificial Heart Valve Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Medical Artificial Heart Valve Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Edwards Lifesciences Basic Information And Sales Area

Table 52: Edwards Lifesciences. Products Portfolio

Table 53: Medtronic Basic Information And Sales Area

Table 54: Medtronic. Products Portfolio

Table 55: Abbott Basic Information And Sales Area

Table 56: Abbott. Products Portfolio

Table 57: Boston Scientific Basic Information And Sales Area

Table 58: Boston Scientific. Products Portfolio

Table 59: Venus Medtech Basic Information And Sales Area

Table 60: Venus Medtech. Products Portfolio

Table 61: Meril Life Sciences Basic Information And Sales Area

Table 62: Meril Life Sciences. Products Portfolio

Table 63: Braile Biomedica Basic Information And Sales Area

Table 64: Braile Biomedica. Products Portfolio

Table 65: Symetis SA Basic Information And Sales Area

Table 66: Symetis SA. Products Portfolio

Table 67: Jenavalve Technology Basic Information And Sales Area

Table 68: Jenavalve Technology. Products Portfolio

Table 69: Lepu Medical Technology Basic Information And Sales Area

Table 70: Lepu Medical Technology. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Medical Artificial Heart Valve Market Value (USD Million) By Region

Table 80: Global Medical Artificial Heart Valve Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Medical Artificial Heart Valve Market Volume (K) By Region

Table 97: Global Medical Artificial Heart Valve Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Medical Artificial Heart Valve Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.99 billion
Growth rate	CAGR of 12.1% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Edwards Lifesciences; Medtronic; Abbott; Boston Scientific; Venus Medtech; Meril Life Sciences; Braile Biomedica; Symetis SA; Jenavalve Technology; Lepu Medical Technology
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Medical Artificial Heart Valve Segmentation Breakdown10 items

Application

Hospitals

Ambulatory Surgical Centers

Types

Spherical Cage Flap

Oblique Disc

Double Leaf Flap

Biopetal with Stent

Biopetal without Stent

Others

Regional Insights

Loading chart…

Competitive Landscape

Edwards Lifesciences: regional expansion

Medtronic: innovation pipeline

Abbott: premium pricing

Boston Scientific: OEM tie-ups

Venus Medtech: local manufacturing

Meril Life Sciences: vertical integration

Key Medical Artificial Heart Valve Companies10 items

Edwards Lifesciences

Medtronic

Abbott

Boston Scientific

Venus Medtech

Meril Life Sciences

Braile Biomedica

Symetis SA

Jenavalve Technology

Lepu Medical Technology

Market Ecosystem

Raw material suppliers — provide biomaterials and components

OEMs / manufacturers — design and produce artificial heart valves

Technology providers — develop valve technologies and software

System integrators / EPCs — integrate valves into larger medical systems

Distributors / channel partners — supply valves to healthcare providers

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents